

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.79748843 |
| 2 | modulation by symbiont of host immune response (GO:0052553) | 5.79748843 |
| 3 | positive regulation by symbiont of host defense response (GO:0052509) | 5.79748843 |
| 4 | modulation by symbiont of host defense response (GO:0052031) | 5.79748843 |
| 5 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.79748843 |
| 6 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.79748843 |
| 7 | positive regulation of cellular amide metabolic process (GO:0034250) | 5.31811568 |
| 8 | negative regulation of cell killing (GO:0031342) | 4.34333608 |
| 9 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.34333608 |
| 10 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 4.33702800 |
| 11 | response to host immune response (GO:0052572) | 4.33702800 |
| 12 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.30293035 |
| 13 | T-helper 1 type immune response (GO:0042088) | 4.14670191 |
| 14 | macrophage activation involved in immune response (GO:0002281) | 4.12120701 |
| 15 | regulation of gamma-delta T cell activation (GO:0046643) | 4.07942150 |
| 16 | response to host (GO:0075136) | 4.01659346 |
| 17 | response to host defenses (GO:0052200) | 4.01659346 |
| 18 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 4.01659346 |
| 19 | leukocyte aggregation (GO:0070486) | 3.98726341 |
| 20 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.82918830 |
| 21 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.78128696 |
| 22 | detection of molecule of bacterial origin (GO:0032490) | 3.62079477 |
| 23 | neutrophil mediated immunity (GO:0002446) | 3.61495364 |
| 24 | B cell receptor signaling pathway (GO:0050853) | 3.59858285 |
| 25 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.59432376 |
| 26 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.58253891 |
| 27 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.58237883 |
| 28 | positive regulation of interferon-alpha production (GO:0032727) | 3.57992606 |
| 29 | microglial cell activation (GO:0001774) | 3.49732911 |
| 30 | response to pheromone (GO:0019236) | 3.47177223 |
| 31 | negative regulation of interleukin-12 production (GO:0032695) | 3.45005061 |
| 32 | response to peptidoglycan (GO:0032494) | 3.40440394 |
| 33 | response to muramyl dipeptide (GO:0032495) | 3.40328788 |
| 34 | neutrophil activation involved in immune response (GO:0002283) | 3.38339582 |
| 35 | detection of bacterium (GO:0016045) | 3.37084746 |
| 36 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.35578130 |
| 37 | positive regulation of heat generation (GO:0031652) | 3.35373405 |
| 38 | regulation of interferon-alpha production (GO:0032647) | 3.34734353 |
| 39 | I-kappaB phosphorylation (GO:0007252) | 3.34272730 |
| 40 | cAMP catabolic process (GO:0006198) | 3.33664153 |
| 41 | cytokine secretion (GO:0050663) | 3.23487574 |
| 42 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.22933110 |
| 43 | positive regulation of interleukin-17 production (GO:0032740) | 3.19089306 |
| 44 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.18308356 |
| 45 | cellular response to ethanol (GO:0071361) | 3.17964372 |
| 46 | negative regulation of B cell mediated immunity (GO:0002713) | 3.17726998 |
| 47 | negative regulation of immunoglobulin mediated immune response (GO:0002890) | 3.17726998 |
| 48 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 3.16137082 |
| 49 | response to interleukin-15 (GO:0070672) | 3.12024211 |
| 50 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 3.11637879 |
| 51 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.10099672 |
| 52 | negative regulation of T cell mediated immunity (GO:0002710) | 3.07714236 |
| 53 | regulation of memory T cell differentiation (GO:0043380) | 3.07195724 |
| 54 | positive regulation of antigen processing and presentation (GO:0002579) | 3.06146613 |
| 55 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.04862741 |
| 56 | cellular response to interleukin-15 (GO:0071350) | 3.04527909 |
| 57 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 3.03801522 |
| 58 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.02022437 |
| 59 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.01072418 |
| 60 | regulation of mast cell activation (GO:0033003) | 2.95550552 |
| 61 | regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645) | 2.95484830 |
| 62 | cilium or flagellum-dependent cell motility (GO:0001539) | 2.95329674 |
| 63 | cyclic nucleotide catabolic process (GO:0009214) | 2.92092292 |
| 64 | negative regulation of adaptive immune response (GO:0002820) | 2.90439552 |
| 65 | macrophage activation (GO:0042116) | 2.90163500 |
| 66 | response to type I interferon (GO:0034340) | 2.89849627 |
| 67 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.89427878 |
| 68 | regulation of MHC class I biosynthetic process (GO:0045343) | 2.89217231 |
| 69 | granulocyte activation (GO:0036230) | 2.89022020 |
| 70 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.87426547 |
| 71 | regulation of activation of Janus kinase activity (GO:0010533) | 2.87352180 |
| 72 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.86690549 |
| 73 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.86690549 |
| 74 | type I interferon signaling pathway (GO:0060337) | 2.85954287 |
| 75 | cellular response to type I interferon (GO:0071357) | 2.85954287 |
| 76 | regulation of interleukin-6 biosynthetic process (GO:0045408) | 2.85899402 |
| 77 | polyol transport (GO:0015791) | 2.84852864 |
| 78 | myeloid cell activation involved in immune response (GO:0002275) | 2.84673309 |
| 79 | regulation of interleukin-17 production (GO:0032660) | 2.84048279 |
| 80 | defense response to protozoan (GO:0042832) | 2.83810230 |
| 81 | regulation of cellular extravasation (GO:0002691) | 2.83293673 |
| 82 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.82038770 |
| 83 | negative thymic T cell selection (GO:0045060) | 2.80759645 |
| 84 | neutrophil activation (GO:0042119) | 2.80251731 |
| 85 | positive regulation of interleukin-12 production (GO:0032735) | 2.78538089 |
| 86 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.77507686 |
| 87 | regulation of relaxation of muscle (GO:1901077) | 2.77272531 |
| 88 | negative T cell selection (GO:0043383) | 2.77119987 |
| 89 | myeloid leukocyte mediated immunity (GO:0002444) | 2.76271676 |
| 90 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition | 2.76161684 |
| 91 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.75438352 |
| 92 | activated T cell proliferation (GO:0050798) | 2.73556679 |
| 93 | NIK/NF-kappaB signaling (GO:0038061) | 2.73385997 |
| 94 | positive regulation of B cell differentiation (GO:0045579) | 2.73161860 |
| 95 | regulation of B cell differentiation (GO:0045577) | 2.72635932 |
| 96 | natural killer cell mediated cytotoxicity (GO:0042267) | 2.72440793 |
| 97 | natural killer cell mediated immunity (GO:0002228) | 2.72440793 |
| 98 | regulation of heat generation (GO:0031650) | 2.72238938 |
| 99 | superoxide anion generation (GO:0042554) | 2.71529318 |
| 100 | germinal center formation (GO:0002467) | 2.70225903 |
| 101 | positive regulation of natural killer cell activation (GO:0032816) | 2.70022578 |
| 102 | dendritic cell migration (GO:0036336) | 2.69977114 |
| 103 | response to interferon-alpha (GO:0035455) | 2.69136092 |
| 104 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.68927683 |
| 105 | detection of other organism (GO:0098543) | 2.68550339 |
| 106 | positive regulation of p38MAPK cascade (GO:1900745) | 2.68401480 |
| 107 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.67866279 |
| 108 | positive regulation of mast cell activation (GO:0033005) | 2.67666227 |
| 109 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.67208979 |
| 110 | positive thymic T cell selection (GO:0045059) | 2.66630052 |
| 111 | positive T cell selection (GO:0043368) | 2.66099097 |
| 112 | cellular extravasation (GO:0045123) | 2.64947604 |
| 113 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.64747905 |
| 114 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.64231063 |
| 115 | phosphatidylglycerol biosynthetic process (GO:0006655) | 2.64173293 |
| 116 | head development (GO:0060322) | 2.63901564 |
| 117 | detection of biotic stimulus (GO:0009595) | 2.63857756 |
| 118 | modulation by symbiont of host cellular process (GO:0044068) | 2.62193605 |
| 119 | positive regulation of granulocyte differentiation (GO:0030854) | 2.61530649 |
| 120 | regulation of antigen processing and presentation (GO:0002577) | 2.61339896 |
| 121 | detection of external biotic stimulus (GO:0098581) | 2.60918403 |
| 122 | B cell mediated immunity (GO:0019724) | 2.60660714 |
| 123 | negative regulation of lipid storage (GO:0010888) | 2.60544099 |
| 124 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 2.60445582 |
| 125 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 2.60196960 |
| 126 | regulation of MHC class II biosynthetic process (GO:0045346) | 2.59928086 |
| 127 | interferon-gamma production (GO:0032609) | 2.59116099 |
| 128 | protein K11-linked deubiquitination (GO:0035871) | 2.58570706 |
| 129 | wound healing, spreading of cells (GO:0044319) | 2.58087319 |
| 130 | L-amino acid import (GO:0043092) | 2.54503444 |
| 131 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 2.53742839 |
| 132 | cell adhesion mediated by integrin (GO:0033627) | 2.53565483 |
| 133 | respiratory burst (GO:0045730) | 2.51182261 |
| 134 | wound healing, spreading of epidermal cells (GO:0035313) | 2.50821153 |
| 135 | regulation of cholesterol storage (GO:0010885) | 2.48984442 |
| 136 | cellular response to virus (GO:0098586) | 2.48725738 |
| 137 | positive regulation of interleukin-1 beta secretion (GO:0050718) | 2.48661750 |
| 138 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.47644304 |
| 139 | dicarboxylic acid biosynthetic process (GO:0043650) | 2.47214433 |
| 140 | glycogen catabolic process (GO:0005980) | 2.46837347 |
| 141 | regulation of interleukin-1 beta secretion (GO:0050706) | 2.46260052 |
| 142 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.45121316 |
| 143 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.45121316 |
| 144 | cellular polysaccharide catabolic process (GO:0044247) | 2.43850748 |
| 145 | phospholipid homeostasis (GO:0055091) | 2.43758862 |
| 146 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.43288121 |
| 147 | positive regulation of interferon-beta production (GO:0032728) | 2.41771437 |
| 148 | immunoglobulin mediated immune response (GO:0016064) | 2.40596841 |
| 149 | glucan catabolic process (GO:0009251) | 2.40263170 |
| 150 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.39723891 |
| 151 | negative regulation of viral genome replication (GO:0045071) | 2.39168384 |
| 152 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.39064510 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.86084548 |
| 2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.06212241 |
| 3 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.64431673 |
| 4 | GATA1_22025678_ChIP-Seq_K562_Human | 3.49929175 |
| 5 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 3.23714687 |
| 6 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.21233866 |
| 7 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.03386391 |
| 8 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.83147675 |
| 9 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.83010936 |
| 10 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.57767698 |
| 11 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.32507783 |
| 12 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.32250103 |
| 13 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.23778614 |
| 14 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.21183289 |
| 15 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.20367412 |
| 16 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.04181124 |
| 17 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.99780174 |
| 18 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.98578968 |
| 19 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.92312470 |
| 20 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.87122019 |
| 21 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.83663916 |
| 22 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.81816500 |
| 23 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.72193595 |
| 24 | RXR_22108803_ChIP-Seq_LS180_Human | 1.71585630 |
| 25 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.67659947 |
| 26 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.57729424 |
| 27 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.55977441 |
| 28 | * GATA3_26560356_Chip-Seq_TH2_Human | 1.54607182 |
| 29 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.54086537 |
| 30 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.52380273 |
| 31 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.51631703 |
| 32 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 1.49235212 |
| 33 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.49114754 |
| 34 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.48760944 |
| 35 | VDR_22108803_ChIP-Seq_LS180_Human | 1.44156227 |
| 36 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.42197607 |
| 37 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.40712110 |
| 38 | SPI1_23127762_ChIP-Seq_K562_Human | 1.39841889 |
| 39 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.38209287 |
| 40 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.38209287 |
| 41 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.37533631 |
| 42 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.36668314 |
| 43 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.34957051 |
| 44 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.33338515 |
| 45 | CJUN_26792858_Chip-Seq_BT549_Human | 1.32321660 |
| 46 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.31916780 |
| 47 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.31438274 |
| 48 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.30771858 |
| 49 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.30552220 |
| 50 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.30062179 |
| 51 | STAT3_23295773_ChIP-Seq_U87_Human | 1.29948319 |
| 52 | SMRT_27268052_Chip-Seq_Bcells_Human | 1.26536436 |
| 53 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.23976590 |
| 54 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.22936493 |
| 55 | TP53_16413492_ChIP-PET_HCT116_Human | 1.22620279 |
| 56 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.21451296 |
| 57 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.21170177 |
| 58 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.20899361 |
| 59 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.20823225 |
| 60 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.19329981 |
| 61 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.18690464 |
| 62 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.18415761 |
| 63 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.18334043 |
| 64 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.17948773 |
| 65 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.17021504 |
| 66 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.16862429 |
| 67 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.15661030 |
| 68 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.15390098 |
| 69 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.14430997 |
| 70 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.13448301 |
| 71 | TCF4_23295773_ChIP-Seq_U87_Human | 1.12884579 |
| 72 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.12462334 |
| 73 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.11607639 |
| 74 | * EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.10919375 |
| 75 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.10679215 |
| 76 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.09983904 |
| 77 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.09836222 |
| 78 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.09796653 |
| 79 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.09137517 |
| 80 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.08612147 |
| 81 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.07845171 |
| 82 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.06705164 |
| 83 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.05896868 |
| 84 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.05732686 |
| 85 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.04443602 |
| 86 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.02887932 |
| 87 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.02855545 |
| 88 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.02792630 |
| 89 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.02558541 |
| 90 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.01063615 |
| 91 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.00081870 |
| 92 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.99789759 |
| 93 | * TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.98507353 |
| 94 | * POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.98507353 |
| 95 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 0.98229905 |
| 96 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.97590093 |
| 97 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.97551234 |
| 98 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.97284741 |
| 99 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.96897615 |
| 100 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 0.96734325 |
| 101 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 0.96580823 |
| 102 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 0.95487205 |
| 103 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.95095926 |
| 104 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.94846216 |
| 105 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.94790464 |
| 106 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.94790464 |
| 107 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.94600540 |
| 108 | GBX2_23144817_ChIP-Seq_PC3_Human | 0.94553236 |
| 109 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.94239097 |
| 110 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.93790912 |
| 111 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.92860027 |
| 112 | * CDX2_22108803_ChIP-Seq_LS180_Human | 0.92626288 |
| 113 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 0.92165659 |
| 114 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.92121286 |
| 115 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.91840729 |
| 116 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 0.91546072 |
| 117 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.90906151 |
| 118 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.90377099 |
| 119 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.90209081 |
| 120 | AR_25329375_ChIP-Seq_VCAP_Human | 0.89618573 |
| 121 | * GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.88924863 |
| 122 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.88181216 |
| 123 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.87703780 |
| 124 | P300_19829295_ChIP-Seq_ESCs_Human | 0.86649431 |
| 125 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.85384489 |
| 126 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.85309695 |
| 127 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.84902914 |
| 128 | GATA2_19941826_ChIP-Seq_K562_Human | 0.84786547 |
| 129 | MYB_26560356_Chip-Seq_TH1_Human | 0.84462439 |
| 130 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.84363373 |
| 131 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.82660245 |
| 132 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 0.82493936 |
| 133 | LMO2_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.82070449 |
| 134 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.81367129 |
| 135 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.80670329 |
| 136 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.80187077 |
| 137 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.79861671 |
| 138 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.79839556 |
| 139 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.79146452 |
| 140 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.78678018 |
| 141 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.78670252 |
| 142 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.77077431 |
| 143 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.76607376 |
| 144 | MYB_26560356_Chip-Seq_TH2_Human | 0.76447383 |
| 145 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.76411685 |
| 146 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.76259167 |
| 147 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.75630976 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0000569_abnormal_digit_pigmentation | 5.30741591 |
| 2 | MP0001835_abnormal_antigen_presentation | 3.42818152 |
| 3 | MP0003136_yellow_coat_color | 3.09569840 |
| 4 | MP0005058_abnormal_lysosome_morphology | 2.70684438 |
| 5 | MP0002419_abnormal_innate_immunity | 2.66550067 |
| 6 | MP0005387_immune_system_phenotype | 2.56719408 |
| 7 | MP0001790_abnormal_immune_system | 2.56719408 |
| 8 | MP0002254_reproductive_system_inflammat | 2.52604718 |
| 9 | MP0000015_abnormal_ear_pigmentation | 2.44621282 |
| 10 | MP0009785_altered_susceptibility_to | 2.40087888 |
| 11 | MP0001853_heart_inflammation | 2.30978157 |
| 12 | MP0003436_decreased_susceptibility_to | 2.24314474 |
| 13 | MP0000685_abnormal_immune_system | 2.22185256 |
| 14 | MP0003172_abnormal_lysosome_physiology | 2.21680808 |
| 15 | MP0002148_abnormal_hypersensitivity_rea | 2.11215398 |
| 16 | MP0005025_abnormal_response_to | 2.11106700 |
| 17 | MP0005670_abnormal_white_adipose | 2.10711466 |
| 18 | MP0008438_abnormal_cutaneous_collagen | 2.02992043 |
| 19 | MP0003303_peritoneal_inflammation | 2.02967060 |
| 20 | MP0005000_abnormal_immune_tolerance | 1.99576788 |
| 21 | MP0002452_abnormal_antigen_presenting | 1.94129738 |
| 22 | MP0003195_calcinosis | 1.93287619 |
| 23 | MP0003690_abnormal_glial_cell | 1.90011992 |
| 24 | MP0003763_abnormal_thymus_physiology | 1.89060207 |
| 25 | MP0003191_abnormal_cellular_cholesterol | 1.87353673 |
| 26 | MP0003724_increased_susceptibility_to | 1.85332282 |
| 27 | MP0001873_stomach_inflammation | 1.82491659 |
| 28 | MP0004381_abnormal_hair_follicle | 1.81269098 |
| 29 | MP0003075_altered_response_to | 1.79906673 |
| 30 | MP0005464_abnormal_platelet_physiology | 1.76498130 |
| 31 | MP0001800_abnormal_humoral_immune | 1.75426986 |
| 32 | MP0005166_decreased_susceptibility_to | 1.75039550 |
| 33 | MP0005409_darkened_coat_color | 1.71586109 |
| 34 | MP0003183_abnormal_peptide_metabolism | 1.66855314 |
| 35 | MP0005075_abnormal_melanosome_morpholog | 1.62831847 |
| 36 | MP0002723_abnormal_immune_serum | 1.62226494 |
| 37 | MP0009764_decreased_sensitivity_to | 1.60723477 |
| 38 | MP0004947_skin_inflammation | 1.55565437 |
| 39 | MP0009278_abnormal_bone_marrow | 1.52229816 |
| 40 | MP0001819_abnormal_immune_cell | 1.51712758 |
| 41 | MP0005671_abnormal_response_to | 1.51690861 |
| 42 | MP0003566_abnormal_cell_adhesion | 1.51122331 |
| 43 | MP0000465_gastrointestinal_hemorrhage | 1.51029025 |
| 44 | MP0005646_abnormal_pituitary_gland | 1.50587888 |
| 45 | MP0004858_abnormal_nervous_system | 1.50441058 |
| 46 | MP0008057_abnormal_DNA_replication | 1.50333892 |
| 47 | MP0003866_abnormal_defecation | 1.49257112 |
| 48 | MP0002420_abnormal_adaptive_immunity | 1.48743698 |
| 49 | MP0000371_diluted_coat_color | 1.48549031 |
| 50 | MP0002234_abnormal_pharynx_morphology | 1.45158229 |
| 51 | MP0004883_abnormal_blood_vessel | 1.44135370 |
| 52 | MP0000689_abnormal_spleen_morphology | 1.42316090 |
| 53 | MP0005174_abnormal_tail_pigmentation | 1.40985665 |
| 54 | MP0004510_myositis | 1.35536457 |
| 55 | MP0003300_gastrointestinal_ulcer | 1.34621261 |
| 56 | MP0001533_abnormal_skeleton_physiology | 1.33541956 |
| 57 | MP0005257_abnormal_intraocular_pressure | 1.33050812 |
| 58 | MP0002722_abnormal_immune_system | 1.30374924 |
| 59 | MP0001958_emphysema | 1.29370475 |
| 60 | MP0000372_irregular_coat_pigmentation | 1.28472674 |
| 61 | MP0000566_synostosis | 1.28230288 |
| 62 | MP0003045_fibrosis | 1.27485490 |
| 63 | MP0001346_abnormal_lacrimal_gland | 1.27148790 |
| 64 | MP0006082_CNS_inflammation | 1.26061438 |
| 65 | MP0002396_abnormal_hematopoietic_system | 1.25876763 |
| 66 | MP0005360_urolithiasis | 1.24658293 |
| 67 | MP0010155_abnormal_intestine_physiology | 1.21246249 |
| 68 | MP0001501_abnormal_sleep_pattern | 1.20965498 |
| 69 | MP0001845_abnormal_inflammatory_respons | 1.19589123 |
| 70 | MP0005164_abnormal_response_to | 1.18840235 |
| 71 | MP0003705_abnormal_hypodermis_morpholog | 1.18680314 |
| 72 | MP0004782_abnormal_surfactant_physiolog | 1.16149960 |
| 73 | MP0002132_abnormal_respiratory_system | 1.16041492 |
| 74 | MP0000343_altered_response_to | 1.13608421 |
| 75 | MP0003656_abnormal_erythrocyte_physiolo | 1.12576662 |
| 76 | MP0003091_abnormal_cell_migration | 1.10884345 |
| 77 | MP0008469_abnormal_protein_level | 1.10724266 |
| 78 | MP0003828_pulmonary_edema | 1.10515354 |
| 79 | MP0003448_altered_tumor_morphology | 1.10477124 |
| 80 | MP0002998_abnormal_bone_remodeling | 1.08189031 |
| 81 | MP0003646_muscle_fatigue | 1.07905410 |
| 82 | MP0009840_abnormal_foam_cell | 1.06992881 |
| 83 | MP0001986_abnormal_taste_sensitivity | 1.06598986 |
| 84 | MP0000703_abnormal_thymus_morphology | 1.05878763 |
| 85 | MP0002168_other_aberrant_phenotype | 1.04705143 |
| 86 | MP0000604_amyloidosis | 1.04665021 |
| 87 | MP0002277_abnormal_respiratory_mucosa | 1.01326428 |
| 88 | MP0002405_respiratory_system_inflammati | 0.99327536 |
| 89 | MP0005076_abnormal_cell_differentiation | 0.96870437 |
| 90 | MP0003252_abnormal_bile_duct | 0.96472394 |
| 91 | MP0004484_altered_response_of | 0.96057052 |
| 92 | MP0000716_abnormal_immune_system | 0.95790801 |
| 93 | MP0005310_abnormal_salivary_gland | 0.94190163 |
| 94 | MP0000427_abnormal_hair_cycle | 0.93947292 |
| 95 | MP0001293_anophthalmia | 0.92535700 |
| 96 | MP0004043_abnormal_pH_regulation | 0.91814448 |
| 97 | MP0002928_abnormal_bile_duct | 0.91165764 |
| 98 | MP0005377_hearing/vestibular/ear_phenot | 0.89172498 |
| 99 | MP0003878_abnormal_ear_physiology | 0.89172498 |
| 100 | MP0002138_abnormal_hepatobiliary_system | 0.89053217 |
| 101 | MP0005397_hematopoietic_system_phenotyp | 0.88107427 |
| 102 | MP0001545_abnormal_hematopoietic_system | 0.88107427 |
| 103 | MP0001851_eye_inflammation | 0.87940645 |
| 104 | MP0002177_abnormal_outer_ear | 0.86938927 |
| 105 | MP0005197_abnormal_uvea_morphology | 0.85355797 |
| 106 | MP0005171_absent_coat_pigmentation | 0.83118064 |
| 107 | MP0002095_abnormal_skin_pigmentation | 0.81755743 |
| 108 | MP0004130_abnormal_muscle_cell | 0.81699883 |
| 109 | MP0010329_abnormal_lipoprotein_level | 0.81206749 |
| 110 | MP0001915_intracranial_hemorrhage | 0.80840407 |
| 111 | MP0006054_spinal_hemorrhage | 0.80590293 |
| 112 | MP0003943_abnormal_hepatobiliary_system | 0.80202640 |
| 113 | MP0002089_abnormal_postnatal_growth/wei | 0.79446176 |
| 114 | MP0002398_abnormal_bone_marrow | 0.79399371 |
| 115 | MP0000767_abnormal_smooth_muscle | 0.78316337 |
| 116 | MP0009763_increased_sensitivity_to | 0.77938913 |
| 117 | MP0002166_altered_tumor_susceptibility | 0.75433102 |
| 118 | MP0002332_abnormal_exercise_endurance | 0.74813782 |
| 119 | MP0002006_tumorigenesis | 0.74006929 |
| 120 | MP0001299_abnormal_eye_distance/ | 0.73992585 |
| 121 | MP0002693_abnormal_pancreas_physiology | 0.73659774 |
| 122 | MP0005167_abnormal_blood-brain_barrier | 0.72740483 |
| 123 | MP0001663_abnormal_digestive_system | 0.72159323 |
| 124 | MP0002933_joint_inflammation | 0.72132766 |
| 125 | MP0004808_abnormal_hematopoietic_stem | 0.71777925 |
| 126 | MP0005376_homeostasis/metabolism_phenot | 0.71777362 |
| 127 | MP0005390_skeleton_phenotype | 0.71726154 |
| 128 | MP0008260_abnormal_autophagy | 0.70864248 |
| 129 | MP0002429_abnormal_blood_cell | 0.70762243 |
| 130 | MP0001324_abnormal_eye_pigmentation | 0.68256554 |
| 131 | MP0000249_abnormal_blood_vessel | 0.67929723 |
| 132 | MP0009115_abnormal_fat_cell | 0.67429165 |
| 133 | MP0005085_abnormal_gallbladder_physiolo | 0.65327316 |
| 134 | MP0009765_abnormal_xenobiotic_induced | 0.63060696 |
| 135 | MP0000470_abnormal_stomach_morphology | 0.60140625 |
| 136 | MP0000383_abnormal_hair_follicle | 0.59098104 |
| 137 | MP0000230_abnormal_systemic_arterial | 0.58136532 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 4.44791598 |
| 2 | Recurrent bacterial skin infections (HP:0005406) | 4.41948962 |
| 3 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.33011095 |
| 4 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 4.13243894 |
| 5 | Autoimmune thrombocytopenia (HP:0001973) | 4.08571894 |
| 6 | Eczematoid dermatitis (HP:0000976) | 4.06411275 |
| 7 | Prostate neoplasm (HP:0100787) | 3.84058041 |
| 8 | Mediastinal lymphadenopathy (HP:0100721) | 3.65947362 |
| 9 | Spinal cord lesions (HP:0100561) | 3.48262242 |
| 10 | Syringomyelia (HP:0003396) | 3.48262242 |
| 11 | Gingivitis (HP:0000230) | 3.37014308 |
| 12 | Abnormality of T cell number (HP:0011839) | 3.30031077 |
| 13 | Abnormality of macrophages (HP:0004311) | 3.27256401 |
| 14 | Gastrointestinal infarctions (HP:0005244) | 3.24451656 |
| 15 | Retrobulbar optic neuritis (HP:0100654) | 3.23567274 |
| 16 | Optic neuritis (HP:0100653) | 3.23567274 |
| 17 | Orchitis (HP:0100796) | 3.19352283 |
| 18 | Periodontitis (HP:0000704) | 3.04446249 |
| 19 | Encephalitis (HP:0002383) | 3.03515419 |
| 20 | Meningitis (HP:0001287) | 2.99817023 |
| 21 | T lymphocytopenia (HP:0005403) | 2.98517804 |
| 22 | Genetic anticipation (HP:0003743) | 2.96132795 |
| 23 | Hypoplasia of the fovea (HP:0007750) | 2.90908013 |
| 24 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 2.90908013 |
| 25 | Myositis (HP:0100614) | 2.90881872 |
| 26 | Spontaneous hematomas (HP:0007420) | 2.87869845 |
| 27 | Stomach cancer (HP:0012126) | 2.87843058 |
| 28 | Abnormality of T cells (HP:0002843) | 2.83549974 |
| 29 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.79491915 |
| 30 | Alopecia of scalp (HP:0002293) | 2.78710423 |
| 31 | Abnormality of T cell physiology (HP:0011840) | 2.78062293 |
| 32 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.76843228 |
| 33 | Tetraparesis (HP:0002273) | 2.75433536 |
| 34 | Aplasia/Hypoplasia of the macula (HP:0008059) | 2.71827214 |
| 35 | Hypochromic microcytic anemia (HP:0004840) | 2.70046239 |
| 36 | Systemic lupus erythematosus (HP:0002725) | 2.70015096 |
| 37 | Myocardial infarction (HP:0001658) | 2.68876244 |
| 38 | Recurrent bronchitis (HP:0002837) | 2.64693098 |
| 39 | Recurrent skin infections (HP:0001581) | 2.64279797 |
| 40 | Tubulointerstitial nephritis (HP:0001970) | 2.63986342 |
| 41 | Hypoglycemic seizures (HP:0002173) | 2.61587422 |
| 42 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.60951302 |
| 43 | Inflammation of the large intestine (HP:0002037) | 2.57130031 |
| 44 | Vasculitis (HP:0002633) | 2.54716248 |
| 45 | Leukocytosis (HP:0001974) | 2.52796373 |
| 46 | Hypochromic anemia (HP:0001931) | 2.51730336 |
| 47 | Obstructive lung disease (HP:0006536) | 2.50909637 |
| 48 | Chronic obstructive pulmonary disease (HP:0006510) | 2.50909637 |
| 49 | Gaze-evoked nystagmus (HP:0000640) | 2.48567817 |
| 50 | Chest pain (HP:0100749) | 2.47819523 |
| 51 | Prolonged bleeding time (HP:0003010) | 2.47411475 |
| 52 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.46808324 |
| 53 | Absent/shortened dynein arms (HP:0200106) | 2.46808324 |
| 54 | Panhypogammaglobulinemia (HP:0003139) | 2.45464232 |
| 55 | Autoimmune hemolytic anemia (HP:0001890) | 2.45330005 |
| 56 | Eosinophilia (HP:0001880) | 2.42170312 |
| 57 | Hyperventilation (HP:0002883) | 2.40770117 |
| 58 | Urticaria (HP:0001025) | 2.40634403 |
| 59 | Ectropion (HP:0000656) | 2.40596719 |
| 60 | Recurrent fungal infections (HP:0002841) | 2.40147213 |
| 61 | Renal cortical cysts (HP:0000803) | 2.39156182 |
| 62 | Aplasia/Hypoplasia affecting the retina (HP:0008061) | 2.37115890 |
| 63 | Thick nail (HP:0001805) | 2.37079722 |
| 64 | Chronic diarrhea (HP:0002028) | 2.35570898 |
| 65 | Pulmonary infiltrates (HP:0002113) | 2.35419388 |
| 66 | Absent frontal sinuses (HP:0002688) | 2.33916158 |
| 67 | Gingival bleeding (HP:0000225) | 2.33150249 |
| 68 | Abnormality of B cell number (HP:0010975) | 2.30247733 |
| 69 | Pancreatic cysts (HP:0001737) | 2.28452689 |
| 70 | Recurrent sinusitis (HP:0011108) | 2.26256443 |
| 71 | Congenital stationary night blindness (HP:0007642) | 2.25734051 |
| 72 | Poor head control (HP:0002421) | 2.25563047 |
| 73 | Pulmonary embolism (HP:0002204) | 2.25089589 |
| 74 | Attenuation of retinal blood vessels (HP:0007843) | 2.24843068 |
| 75 | Gastrointestinal inflammation (HP:0004386) | 2.24495042 |
| 76 | Bone pain (HP:0002653) | 2.22292532 |
| 77 | Congenital sensorineural hearing impairment (HP:0008527) | 2.20568467 |
| 78 | Increased IgE level (HP:0003212) | 2.18987718 |
| 79 | Granulocytopenia (HP:0001913) | 2.17872378 |
| 80 | Chronic otitis media (HP:0000389) | 2.17371643 |
| 81 | Aplasia cutis congenita (HP:0001057) | 2.17249902 |
| 82 | Episodic fever (HP:0001954) | 2.16625578 |
| 83 | Abnormality of eosinophils (HP:0001879) | 2.15420220 |
| 84 | Epistaxis (HP:0000421) | 2.15136559 |
| 85 | Stomatitis (HP:0010280) | 2.13054222 |
| 86 | Premature loss of primary teeth (HP:0006323) | 2.12893560 |
| 87 | Progressive cerebellar ataxia (HP:0002073) | 2.12880748 |
| 88 | Abnormality of the pleura (HP:0002103) | 2.11703084 |
| 89 | Recurrent pneumonia (HP:0006532) | 2.11547538 |
| 90 | Pustule (HP:0200039) | 2.10486967 |
| 91 | Abnormality of the prostate (HP:0008775) | 2.08980686 |
| 92 | Recurrent viral infections (HP:0004429) | 2.08240133 |
| 93 | Abnormal ciliary motility (HP:0012262) | 2.08190205 |
| 94 | Thyroiditis (HP:0100646) | 2.07989056 |
| 95 | Abnormality of primary teeth (HP:0006481) | 2.07927546 |
| 96 | Osteomyelitis (HP:0002754) | 2.07429202 |
| 97 | Anorexia (HP:0002039) | 2.06661013 |
| 98 | Arterial thrombosis (HP:0004420) | 2.06467023 |
| 99 | Gangrene (HP:0100758) | 2.04496628 |
| 100 | Abnormality of the lumbar spine (HP:0100712) | 2.04338386 |
| 101 | Basal ganglia calcification (HP:0002135) | 2.03902249 |
| 102 | Abnormality of the fovea (HP:0000493) | 2.03550800 |
| 103 | Symptomatic seizures (HP:0011145) | 2.02188467 |
| 104 | Microvesicular hepatic steatosis (HP:0001414) | 2.01983852 |
| 105 | Facial diplegia (HP:0001349) | 2.01685475 |
| 106 | Colitis (HP:0002583) | 1.99298806 |
| 107 | Widely spaced teeth (HP:0000687) | 1.98649148 |
| 108 | Vacuolated lymphocytes (HP:0001922) | 1.98514770 |
| 109 | Clumsiness (HP:0002312) | 1.97845620 |
| 110 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.96846936 |
| 111 | Abnormality of the renal cortex (HP:0011035) | 1.96637048 |
| 112 | Albinism (HP:0001022) | 1.95913302 |
| 113 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.94931100 |
| 114 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.94931100 |
| 115 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.94931100 |
| 116 | Joint hemorrhage (HP:0005261) | 1.93997875 |
| 117 | Abnormal rod and cone electroretinograms (HP:0008323) | 1.92587740 |
| 118 | Hemoptysis (HP:0002105) | 1.91384706 |
| 119 | Narrow palate (HP:0000189) | 1.91217187 |
| 120 | Keratitis (HP:0000491) | 1.90994642 |
| 121 | Keratoconjunctivitis sicca (HP:0001097) | 1.90432930 |
| 122 | Decreased circulating renin level (HP:0003351) | 1.89536365 |
| 123 | Increased cerebral lipofuscin (HP:0011813) | 1.89528912 |
| 124 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 1.89356047 |
| 125 | Fair hair (HP:0002286) | 1.88477785 |
| 126 | Macular degeneration (HP:0000608) | 1.87844916 |
| 127 | Bronchiectasis (HP:0002110) | 1.86971940 |
| 128 | Skull defect (HP:0001362) | 1.86902320 |
| 129 | Cellulitis (HP:0100658) | 1.86714040 |
| 130 | Bronchitis (HP:0012387) | 1.85906582 |
| 131 | Turricephaly (HP:0000262) | 1.85495799 |
| 132 | Lymphopenia (HP:0001888) | 1.85269081 |
| 133 | Nephritis (HP:0000123) | 1.84683902 |
| 134 | Chronic sinusitis (HP:0011109) | 1.84442600 |
| 135 | Hematochezia (HP:0002573) | 1.83517564 |
| 136 | Enlarged kidneys (HP:0000105) | 1.82841314 |
| 137 | Axonal loss (HP:0003447) | 1.82187737 |
| 138 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.81475022 |
| 139 | Recurrent cutaneous fungal infections (HP:0011370) | 1.81475022 |
| 140 | Short nail (HP:0001799) | 1.78532474 |
| 141 | Recurrent lower respiratory tract infections (HP:0002783) | 1.78159272 |
| 142 | Amyloidosis (HP:0011034) | 1.77615603 |
| 143 | Abnormality of the renal collecting system (HP:0004742) | 1.77335664 |
| 144 | Mucopolysacchariduria (HP:0008155) | 1.76926386 |
| 145 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.76926386 |
| 146 | Abnormality of incisor morphology (HP:0011063) | 1.76581970 |
| 147 | Keratoconjunctivitis (HP:0001096) | 1.76578847 |
| 148 | Osteolytic defects of the hand bones (HP:0009699) | 1.74810910 |
| 149 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.74810910 |
| 150 | Hyperlipoproteinemia (HP:0010980) | 1.73470223 |
| 151 | Conical tooth (HP:0000698) | 1.73015310 |
| 152 | Long toe (HP:0010511) | 1.72961422 |
| 153 | Restrictive lung disease (HP:0002091) | 1.72185557 |
| 154 | Follicular hyperkeratosis (HP:0007502) | 1.72150780 |
| 155 | Femoral bowing (HP:0002980) | 1.71968903 |
| 156 | Mitral stenosis (HP:0001718) | 1.70432746 |
| 157 | Pathologic fracture (HP:0002756) | 1.69509110 |
| 158 | Hydroxyprolinuria (HP:0003080) | 1.68833020 |
| 159 | Abnormality of proline metabolism (HP:0010907) | 1.68833020 |
| 160 | Tetany (HP:0001281) | 1.67657481 |
| 161 | Glomerulonephritis (HP:0000099) | 1.65406168 |
| 162 | Cupped ear (HP:0000378) | 1.64931184 |
| 163 | Peritonitis (HP:0002586) | 1.62335672 |
| 164 | Ulnar bowing (HP:0003031) | 1.61629302 |
| 165 | Distal lower limb amyotrophy (HP:0008944) | 1.60413558 |
| 166 | Hypoglycemic coma (HP:0001325) | 1.60004530 |
| 167 | Radial bowing (HP:0002986) | 1.59282893 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP3K14 | 4.07967983 |
| 2 | STK10 | 3.97810530 |
| 3 | MARK3 | 3.84233946 |
| 4 | TYK2 | 3.37759005 |
| 5 | IRAK3 | 3.17566038 |
| 6 | PRKD3 | 2.74625827 |
| 7 | MAP3K13 | 2.48243032 |
| 8 | JAK1 | 2.34917125 |
| 9 | RIPK4 | 2.34681447 |
| 10 | JAK3 | 2.33520183 |
| 11 | TNK2 | 2.11304271 |
| 12 | ACVR1B | 2.10134245 |
| 13 | MAPK13 | 1.92058152 |
| 14 | SIK3 | 1.90293677 |
| 15 | MAP2K3 | 1.89528622 |
| 16 | IRAK4 | 1.86397485 |
| 17 | IKBKB | 1.67346769 |
| 18 | IKBKE | 1.64012128 |
| 19 | KIT | 1.63281752 |
| 20 | IRAK1 | 1.61550160 |
| 21 | TBK1 | 1.61446185 |
| 22 | TAOK3 | 1.59507327 |
| 23 | CAMK1D | 1.54250888 |
| 24 | CHUK | 1.53994537 |
| 25 | GRK6 | 1.52973803 |
| 26 | SIK1 | 1.51001913 |
| 27 | LATS1 | 1.47327634 |
| 28 | EIF2AK2 | 1.46384599 |
| 29 | TTN | 1.44898485 |
| 30 | BMPR1B | 1.44025726 |
| 31 | CDK12 | 1.43910812 |
| 32 | TXK | 1.43562603 |
| 33 | SIK2 | 1.43448641 |
| 34 | TNIK | 1.42295601 |
| 35 | PIM1 | 1.40660410 |
| 36 | TAOK2 | 1.31082340 |
| 37 | PTK2B | 1.26957687 |
| 38 | ADRBK2 | 1.24480268 |
| 39 | FES | 1.22923570 |
| 40 | NUAK1 | 1.22285706 |
| 41 | EPHA3 | 1.20390553 |
| 42 | CASK | 1.18096199 |
| 43 | RIPK1 | 1.12038880 |
| 44 | NLK | 1.10630363 |
| 45 | PIK3CA | 1.05235893 |
| 46 | HCK | 1.04907895 |
| 47 | MAP4K1 | 1.03929180 |
| 48 | MAP3K3 | 1.02866292 |
| 49 | DAPK2 | 1.02007926 |
| 50 | CDK8 | 1.00557228 |
| 51 | ERN1 | 0.99437624 |
| 52 | STK38 | 0.99283554 |
| 53 | FGR | 0.98848523 |
| 54 | BLK | 0.97705296 |
| 55 | PRPF4B | 0.97485140 |
| 56 | CAMK1G | 0.96648582 |
| 57 | BRD4 | 0.94639231 |
| 58 | EPHB1 | 0.93328256 |
| 59 | PTK6 | 0.92067469 |
| 60 | STK3 | 0.90817383 |
| 61 | SGK3 | 0.90767777 |
| 62 | TRPM7 | 0.90340947 |
| 63 | OXSR1 | 0.89004110 |
| 64 | NEK9 | 0.87845807 |
| 65 | YES1 | 0.86945672 |
| 66 | TGFBR2 | 0.86546542 |
| 67 | TIE1 | 0.86061349 |
| 68 | INSRR | 0.85654337 |
| 69 | ADRBK1 | 0.85250773 |
| 70 | MATK | 0.85059131 |
| 71 | PRKCH | 0.84455268 |
| 72 | SGK2 | 0.84023968 |
| 73 | FGFR3 | 0.83340576 |
| 74 | PDK1 | 0.82846000 |
| 75 | MAP3K6 | 0.82077378 |
| 76 | AKT3 | 0.79989446 |
| 77 | CSK | 0.79567292 |
| 78 | MAP2K6 | 0.76817026 |
| 79 | CSF1R | 0.76152403 |
| 80 | BTK | 0.74482736 |
| 81 | MAP3K2 | 0.72685456 |
| 82 | FRK | 0.72405739 |
| 83 | MAP4K2 | 0.72275219 |
| 84 | MST1R | 0.71033731 |
| 85 | JAK2 | 0.70509272 |
| 86 | CLK1 | 0.69518782 |
| 87 | SYK | 0.68427074 |
| 88 | TEC | 0.67679411 |
| 89 | ABL1 | 0.66010168 |
| 90 | FER | 0.65950686 |
| 91 | MAPK11 | 0.64925343 |
| 92 | CAMKK2 | 0.64046904 |
| 93 | HIPK2 | 0.63399353 |
| 94 | LCK | 0.62792609 |
| 95 | FGFR4 | 0.61985644 |
| 96 | LYN | 0.61484074 |
| 97 | MARK2 | 0.60207140 |
| 98 | GRK1 | 0.59305517 |
| 99 | ZAK | 0.58886877 |
| 100 | PAK3 | 0.58346248 |
| 101 | STK24 | 0.56411750 |
| 102 | WNK1 | 0.55729277 |
| 103 | GRK7 | 0.54421801 |
| 104 | PRKCD | 0.54172088 |
| 105 | TAOK1 | 0.52438990 |
| 106 | STK11 | 0.52316396 |
| 107 | PDPK1 | 0.51723525 |
| 108 | MAP3K1 | 0.50743962 |
| 109 | CDC42BPA | 0.50512166 |
| 110 | PRKAA2 | 0.50476456 |
| 111 | BMX | 0.49580131 |
| 112 | CDK6 | 0.47688180 |
| 113 | STK38L | 0.47612666 |
| 114 | NEK6 | 0.46309019 |
| 115 | EGFR | 0.45774861 |
| 116 | PDGFRB | 0.45279253 |
| 117 | PIK3CG | 0.44347338 |
| 118 | PRKCE | 0.44090183 |
| 119 | MAP3K7 | 0.43527239 |
| 120 | SRC | 0.42217607 |
| 121 | CDK3 | 0.41094420 |
| 122 | IRAK2 | 0.40906782 |
| 123 | SGK1 | 0.39684834 |
| 124 | PRKD2 | 0.39647201 |
| 125 | MAP2K4 | 0.38502172 |
| 126 | MAP3K5 | 0.38326396 |
| 127 | ERBB2 | 0.37630911 |
| 128 | RPS6KA6 | 0.37331149 |
| 129 | BMPR2 | 0.37262799 |
| 130 | PKN1 | 0.36470025 |
| 131 | ZAP70 | 0.36353859 |
| 132 | MAPK7 | 0.36349410 |
| 133 | FYN | 0.33755813 |
| 134 | SGK223 | 0.33366810 |
| 135 | SGK494 | 0.33366810 |
| 136 | MELK | 0.33306793 |
| 137 | TGFBR1 | 0.32493566 |
| 138 | PLK2 | 0.31299902 |
| 139 | AKT1 | 0.28727463 |
| 140 | ITK | 0.28723059 |
| 141 | KSR1 | 0.28516056 |
| 142 | PRKCQ | 0.27561210 |
| 143 | ABL2 | 0.27438344 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 5.48607795 |
| 2 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.39963650 |
| 3 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.25849246 |
| 4 | Leishmaniasis_Homo sapiens_hsa05140 | 2.11712894 |
| 5 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.08060966 |
| 6 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.07547744 |
| 7 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.99451916 |
| 8 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.92632157 |
| 9 | Malaria_Homo sapiens_hsa05144 | 1.90238584 |
| 10 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.82005990 |
| 11 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.80442055 |
| 12 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.78804825 |
| 13 | Influenza A_Homo sapiens_hsa05164 | 1.70501021 |
| 14 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.67531293 |
| 15 | Measles_Homo sapiens_hsa05162 | 1.58036975 |
| 16 | Tuberculosis_Homo sapiens_hsa05152 | 1.55995049 |
| 17 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.48518797 |
| 18 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.47552245 |
| 19 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.45928130 |
| 20 | Legionellosis_Homo sapiens_hsa05134 | 1.44650032 |
| 21 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.43174204 |
| 22 | Pertussis_Homo sapiens_hsa05133 | 1.43143377 |
| 23 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.40785445 |
| 24 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.38890866 |
| 25 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.33283757 |
| 26 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.32718996 |
| 27 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.32255624 |
| 28 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.30819459 |
| 29 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.27484127 |
| 30 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.27367565 |
| 31 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.26352596 |
| 32 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.23501540 |
| 33 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.17367631 |
| 34 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.17238578 |
| 35 | Allograft rejection_Homo sapiens_hsa05330 | 1.14579118 |
| 36 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.13886152 |
| 37 | Hepatitis C_Homo sapiens_hsa05160 | 1.11678789 |
| 38 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.11493113 |
| 39 | Lysine degradation_Homo sapiens_hsa00310 | 1.11194488 |
| 40 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.10936570 |
| 41 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.08911771 |
| 42 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 1.05230546 |
| 43 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.02193825 |
| 44 | Lysosome_Homo sapiens_hsa04142 | 0.99399917 |
| 45 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.95573059 |
| 46 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.95032710 |
| 47 | Phagosome_Homo sapiens_hsa04145 | 0.94386297 |
| 48 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.93037855 |
| 49 | Peroxisome_Homo sapiens_hsa04146 | 0.92911751 |
| 50 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.92132398 |
| 51 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.92034060 |
| 52 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.91990402 |
| 53 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.91916034 |
| 54 | Sulfur relay system_Homo sapiens_hsa04122 | 0.91776463 |
| 55 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.91672742 |
| 56 | ABC transporters_Homo sapiens_hsa02010 | 0.90502263 |
| 57 | Apoptosis_Homo sapiens_hsa04210 | 0.90117820 |
| 58 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.87921294 |
| 59 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.87706945 |
| 60 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.85540156 |
| 61 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.85378394 |
| 62 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.85216567 |
| 63 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.84662271 |
| 64 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.80705421 |
| 65 | Hepatitis B_Homo sapiens_hsa05161 | 0.79533272 |
| 66 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.79532492 |
| 67 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.78352403 |
| 68 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.77522371 |
| 69 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.76739305 |
| 70 | Salmonella infection_Homo sapiens_hsa05132 | 0.76736664 |
| 71 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.76479078 |
| 72 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.75565252 |
| 73 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.71192694 |
| 74 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.70790085 |
| 75 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.70629550 |
| 76 | Amoebiasis_Homo sapiens_hsa05146 | 0.70246641 |
| 77 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.68367291 |
| 78 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.67404621 |
| 79 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.67185737 |
| 80 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.66657286 |
| 81 | Other glycan degradation_Homo sapiens_hsa00511 | 0.66254073 |
| 82 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.65419475 |
| 83 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.64809827 |
| 84 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.64767207 |
| 85 | Viral myocarditis_Homo sapiens_hsa05416 | 0.63220602 |
| 86 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.60812676 |
| 87 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.59743737 |
| 88 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.59256752 |
| 89 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.58844780 |
| 90 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.58502766 |
| 91 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.57545153 |
| 92 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.57103221 |
| 93 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.56609068 |
| 94 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.55941159 |
| 95 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.55918879 |
| 96 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.55044318 |
| 97 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.53628885 |
| 98 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.51846677 |
| 99 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.51497418 |
| 100 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.51171848 |
| 101 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.51038654 |
| 102 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.50744584 |
| 103 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.49988114 |
| 104 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.49334083 |
| 105 | Taste transduction_Homo sapiens_hsa04742 | 0.48899064 |
| 106 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.48404619 |
| 107 | Morphine addiction_Homo sapiens_hsa05032 | 0.47700799 |
| 108 | Focal adhesion_Homo sapiens_hsa04510 | 0.47268736 |
| 109 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.47193082 |
| 110 | Insulin resistance_Homo sapiens_hsa04931 | 0.47104082 |
| 111 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.46298549 |
| 112 | Shigellosis_Homo sapiens_hsa05131 | 0.45183265 |
| 113 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.44163101 |
| 114 | Long-term depression_Homo sapiens_hsa04730 | 0.44070981 |
| 115 | Phototransduction_Homo sapiens_hsa04744 | 0.44042493 |
| 116 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.44029403 |
| 117 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.43739128 |
| 118 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.43640779 |
| 119 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.42243005 |
| 120 | Platelet activation_Homo sapiens_hsa04611 | 0.42037558 |
| 121 | Olfactory transduction_Homo sapiens_hsa04740 | 0.41973425 |
| 122 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.41548376 |
| 123 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.41232586 |
| 124 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.41162325 |
| 125 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.40881256 |
| 126 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.40777234 |
| 127 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.40625427 |
| 128 | Glioma_Homo sapiens_hsa05214 | 0.40472434 |
| 129 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.40065420 |
| 130 | Salivary secretion_Homo sapiens_hsa04970 | 0.39858779 |
| 131 | Asthma_Homo sapiens_hsa05310 | 0.39784525 |
| 132 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.39657495 |
| 133 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.39076870 |
| 134 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.38763732 |
| 135 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.38680912 |
| 136 | Bile secretion_Homo sapiens_hsa04976 | 0.37990423 |
| 137 | Prostate cancer_Homo sapiens_hsa05215 | 0.37602493 |
| 138 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.36631886 |
| 139 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.36574565 |
| 140 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.36007268 |

